Application for a clinical RMD research methodology was approved by the EULAR research Committee on the 12th of MARCH 2024, for a total funding of 50’000 Euros.
The EULAR grant for FIARVASC
You may also like
The FAIRVASC consortium will meet for a Plenary meeting in the Conference Center at the Faculty of Medicine in Kraków, Poland on […]
Interview with Prof. Augusto Vaglio about the role and tasks of QIT in FAIRVASC project has been published.
This two-day international webinar is composed of a multi-professional faculty reflecting the multi-systemic nature of vasculitis and autoinflammation. Vasculitis: From cell to […]
One of the tasks of the POLVAS team was to organize and conduct a Hackathon which had 2 aims: 1) to analyse […]